Clinical Trial Update: Thymus Transplantation Dose in DiGeorge #932 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on thymus transplantation dosing for DiGeorge anomaly/syndrome, completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digeorge Anomaly
• Digeorge Syndrome

Drugs mentioned

• thymus transplantation

Snippet

Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: DiGeorge Anomaly, DiGeorge Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-02-17